Researcher.Life Logo

Annals of Pharmacotherapy : Impact Factor & More

eISSN: 1542-6270pISSN: 1060-0280

Aims and Scope of Annals of Pharmacotherapy

The Annals of Pharmacotherapy is a peer-reviewed medical journal covering all aspects of pharmacotherapy. The journal was established in 1967 as Drug Intelligence. The name changed a few times during its history, to Drug Intelligence and Clinical Pharmacy (DICP) in 1969 and DICP-The Annals of Pharmacotherapy in 1989, before obtaining its current name in 1992. Less

Key Metrics

CiteScore
5
H-Index
120
Impact Factor
< 5
SJR
Q1Pharmacology (medical)
SNIP
1.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Annals of Pharmacotherapy

Annals of Pharmacotherapy Journal Specifications

Overview
Publisher SAGE PUBLICATIONS INC
Language Multi-Language
Frequency Monthly
General Details
LanguageMulti-Language
FrequencyMonthly
Publication Start Year1967
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Annals of Pharmacotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Annals of Pharmacotherapy

Evaluation and Optimization of INR Goals in Patients With Mechanical Aortic Valves in a Pharmacist-Run Clinic: An Anticoagulation Stewardship Initiative.
  • 30 Dec 2025
  • The Annals of pharmacotherapy
Estimating GFR Using Creatinine, Cystatin C, or Both and the Impact on Predicted Vancomycin Half-Life.
  • 29 Dec 2025
  • The Annals of pharmacotherapy
Fitusiran: A Novel Antithrombin-Targeting Therapy for Hemophilia A and B, With or Without Inhibitors.
  • 26 Dec 2025
  • The Annals of pharmacotherapy
Evaluation of the Use of Primary Prevention Aspirin in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant for Stroke Prevention.
  • 26 Dec 2025
  • The Annals of pharmacotherapy
Lebrikizumab-lbkz for the Treatment of Atopic Dermatitis: A Drug Review.
  • 26 Dec 2025
  • The Annals of pharmacotherapy
Gabapentinoids in Chronic Kidney Disease: A Closer Look at Respiratory Risk.
  • 26 Dec 2025
  • The Annals of pharmacotherapy
Evaluation and Optimization of INR Goals in Patients With Mechanical Aortic Valves in a Pharmacist-Run Clinic: An Anticoagulation Stewardship Initiative.
  • 30 Dec 2025
  • The Annals of pharmacotherapy
Estimating GFR Using Creatinine, Cystatin C, or Both and the Impact on Predicted Vancomycin Half-Life.
  • 29 Dec 2025
  • The Annals of pharmacotherapy
Fitusiran: A Novel Antithrombin-Targeting Therapy for Hemophilia A and B, With or Without Inhibitors.
  • 26 Dec 2025
  • The Annals of pharmacotherapy
Evaluation of the Use of Primary Prevention Aspirin in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant for Stroke Prevention.
  • 26 Dec 2025
  • The Annals of pharmacotherapy
Lebrikizumab-lbkz for the Treatment of Atopic Dermatitis: A Drug Review.
  • 26 Dec 2025
  • The Annals of pharmacotherapy
Gabapentinoids in Chronic Kidney Disease: A Closer Look at Respiratory Risk.
  • 26 Dec 2025
  • The Annals of pharmacotherapy

FAQs on Annals of Pharmacotherapy